Stratified analysis of multidrug-resistant Escherichia coli in US health care institutions

Postgraduate Medicine

Volumn 120, Issue 3, 2008, Pages

  Sahm, Daniel F ^a   Brown, Nina P ^a   Yee, Y Cheung ^b   Evangelista, Alan T ^b  

^a Eurofins Medinet Inc   (Germany)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Escherichia coli; Fluoroquinolone; Levofloxacin; Multidrug resistance

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; HEALTH CARE; HEALTH CARE FACILITIES AND SERVICES; HEALTH SURVEY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; UNITED STATES; AGE; CLINICAL TRIAL; ENTEROBACTER INFECTION; FACTUAL DATABASE; HEALTH CARE FACILITY; MICROBIOLOGY; MULTICENTER STUDY; RISK FACTOR; STATISTICS;

AGE FACTORS; DATABASES, FACTUAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HEALTH FACILITIES; HUMANS; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 66849108891     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.09.suppl52.285     Document Type: Article

References (22)

1. Cizman M, Orazem A, Krizan-Hergouth V, Kolman J. Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J Antimicrob Chemother. 2001;47(4):502. (Pubitemid 32303427)
2. Ena J, Amador C, Martinez C, Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol. 1995;153(1):117-120. (Pubitemid 24379811)
3. Zhanel GG, Karlowsky JA, Harding GK, et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 2000;44(4):1089-1092. (Pubitemid 30165299)
4. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother. 2001;45(5):1402-1406.
5. Lautenbach E, Strom BL, Nachamkin I, et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients. 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis. 2004;38(5):655-662.
6. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;46(8):2540-2545. (Pubitemid 34793461)
7. Zhanel GG, Hisanaga TL, Laing NM, et al; NAUTICA Group. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2005;26(5):380-388. (Pubitemid 41483468)
8. Zhanel GG, Hisanaga TL, Laing NM, et al; for the NAUTICA Group, Hoban DJ. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2006;27(6):468-475. (Pubitemid 44236020)
9. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33(1):89-94. (Pubitemid 32554508)
10. Zervos MJ, Hershberger E, Nicolau DP, et al. Relationship between fluoroquinolone use and changes insusceptibility to fluoroquinolones of selected pathogens in 10 United States leaching hospitals, 1991-2000. Clin Infect Dis. 2003;37(12):1643-1648. (Pubitemid 37549951)
11. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41(4):435-440. (Pubitemid 41099634)
12. Bolon MK, Wright SB, Gold HS, Carmeli Y. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported. Antimicrob Agents Chemother. 2004;48(6):1934-1940. (Pubitemid 38691579)
13. Nicolle LE. Infeclion control in long-term care facilities. Clin Infect Dis. 2000;31(3):752-756. (Pubitemid 32295497)
14. Nicolle LE. Urinary rract infections in long-term care facilities. Infect Control Hosp Epidemiol. 1993;14(4):220-225.
15. Yang S, Clayton SR, Zechiedrich EL. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother. 2003;51(3):545-556. (Pubitemid 36336146)
16. Jumbe NL, Louie A, Miller MH, et al. Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2006;50(1):310-317.
17. Bush K, Goldschmidt R. Effectiveness of fluoroquinolones against gram-positive bacteria. Curr Opin Investig Drugs. 2000;1(1):22-30.
18. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 1993;175(19):6299-6313.
19. Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994;38(8):1732-1741. (Pubitemid 24250718)
20. Nicolle LE. Urinary tract infection in long-term-care facility residents. Clin Infect Dis. 2000;31(3):757-761. (Pubitemid 32295498)
21. Strausbaugh LJ, Joseph CL. The burden of infection in long-term care. Infect Control Hosp Epidemiol. 2000;21(10):674-679.
22. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001;7(2):188-192. (Pubitemid 32374325)